TKNO vs UHS: fair value comparison
Alpha Teknova, Inc. and Universal Health Services, Inc. · Updated 2026-10-19
TKNO has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, TKNO currently ranks higher by quality score.
| TKNO | UHS | |
|---|---|---|
| Verdict | No estimate yet | Undervalued |
| Last price | $7.08 | $177.35 |
| 12-month range | $1.99–$9.33 | $141.17–$244.18 |
| Rank by discount to fair value | — | #22 of 108 Healthcare |
| Rank by quality score | #123 of 301 Healthcare | #124 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: TKNO fair value analysis · UHS fair value analysis